Coronavirus (COVID-19) Updates


Forbes: 'The inside story behind the pandemic, the CEO and a promising, unproven treatment.'

Pfizer CEO Albert Bourla talks to Forbes about our unprecedented efforts in response to COVID-19.


What impact is COVID-19 having on wider treatments, cancer patients and innovation?

Our UK Oncology Director, Dr Olivia Ashman, joins Clare English on the 17th May 'Ripples' podcast.


Pfizer and BioNTech Start Human Trials as Part of Global COVID-19 Vaccine Development Programme

First U.S. participants have been dosed in the clinical trial for the global vaccine programme.


Inspiring the UK’s next generation of scientists from home

Emma Lynn, Pfizer UK Director of Corporate Affairs, explains how Pfizer is helping to bring science into the homes of children across the UK amid COVID-19.


The power of our people

Ben Osborn, Pfizer UK Managing Director, discusses the essential role that Pfizer colleagues have played and continue to play during the COVID crisis.


Partnerships are critical to unlocking medical breakthroughs in our fight against COVID-19

Pfizer UK R&D leaders discuss the latest scientific developments and the essential role of partnerships during the COVID-19 crisis.


Pfizer UK's Medical Director joins BBC's World Service to discuss R&D efforts in response to the COVID-19 pandemic

Listen back to the 10th April radio broadcast on BBC Sounds using the link above.


Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Pfizer Inc. announces important advances in the battle against the global COVID-19 pandemic.


Pfizer Inc. and The Pfizer Foundation Pledge $40 Million to Help Combat COVID-19 Pandemic

The donation addresses the urgent needs of partners who are working to slow the spread of the virus and strengthen vulnerable healthcare systems.


Pfizer and BioNTech to Co-Develop Potential COVID-19 Vaccine

The collaboration aims to accelerate development of BioNTech’s potential COVID-19 mRNA vaccine programme.


Pfizer Outlines Five-Point Plan to Battle COVID-19

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combatting the global pandemic.

 

PP-PFE-GBR-2631 / June 2020